Cellcept and Serevent drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cellcept (mycophenolate mofetil) and Serevent (salmeterol xinafoate). Common drug interactions include dyspepsia among females and angioneurotic oedema among males.

The phase IV clinical study analyzes what interactions people have when they take Cellcept and Serevent. It is created by eHealthMe based on reports of 38 people who take the same drugs from the FDA, and is updated regularly.

What is Cellcept?

Cellcept has active ingredients of mycophenolate mofetil. It is often used in systemic lupus erythematosus. eHealthMe is studying from 41,872 Cellcept users. Check the latest studies of Cellcept.

What is Serevent?

Serevent has active ingredients of salmeterol xinafoate. It is often used in asthma. eHealthMe is studying from 15,586 Serevent users. Check the latest studies of Serevent.



On Jul, 15, 2026

38 people who take Cellcept and Serevent together, and have interactions are studied.

Cellcept and Serevent drug interactions.

What are the common drug interactions of Cellcept and Serevent, by gender? *:

female:

  1. Dyspepsia (indigestion)
  2. Dyspnoea exertional (breathlessness or shortness of breath)
  3. Gastric ulcer (stomach ulcer)
  4. Headache (pain in head)
  5. Hepatic cyst
  6. Lung infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung)
  7. Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
  8. Multiple allergies (allergy to multiple agents)
  9. Nephroangiosclerosis (death of the renal arterioles associated with high blood pressure)
  10. Palpitations (feelings or sensations that your heart is pounding or racing)

male:

  1. Angioneurotic oedema (swelling that occurs just beneath the surface of the skin or mucous membranes)
  2. Arrhythmia (irregular heartbeat)
  3. Dizziness (excl vertigo)
  4. Transplant rejection (a transplant material is not worked)
  5. Dyspnoea (difficult or laboured respiration)
  6. Pulmonary embolism (blockage of the main artery of the lung)
  7. Pyrexia (fever)
  8. Rash maculo-papular (red area on the skin that is covered with small confluent bumps)
  9. Blood creatinine increased
  10. Cytomegalovirus infection

What are the common drug interactions of Cellcept and Serevent, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Difficulty in walking
  2. Inflammatory bowel disease
  3. Tremor (trembling or shaking movements in one or more parts of your body)

20-29:

n/a

30-39:

  1. Arrhythmia (irregular heartbeat)
  2. Oesophageal candidiasis (fungal infection of oesophagus)
  3. Pseudomonas infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa)
  4. Staphylococcal infection (an infection with staphylococcus bacteria)
  5. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  6. Tremor (trembling or shaking movements in one or more parts of your body)
  7. Transplant rejection (a transplant material is not worked)
  8. Cytomegalovirus infection
  9. Epstein-barr virus associated lymphoproliferative disorder (lymphocytes are produced in excessive quantities associated with epstein-barr virus)
  10. Lymphoma (cancer that begins in immune system cells)

40-49:

  1. Tendonitis (a condition that causes pain and swelling of tendons)
  2. Vena cava embolism (obstruction of large vein carrying deoxygenated blood into the heart)
  3. Pulmonary embolism (blockage of the main artery of the lung)
  4. Alopecia (absence of hair from areas of the body)
  5. Benign breast neoplasm (benign (non-cancerous) tumours of the breast)
  6. Blood pressure diastolic increased
  7. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  8. Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder)
  9. Calcaneal spur (heel spur)
  10. Cellulitis (infection under the skin)

50-59:

  1. Angioneurotic oedema (swelling that occurs just beneath the surface of the skin or mucous membranes)
  2. Diarrhoea
  3. Hypotension (abnormally low blood pressure)
  4. Dizziness (excl vertigo)
  5. Dyspnoea (difficult or laboured respiration)
  6. Nausea (feeling of having an urge to vomit)
  7. Rash maculo-papular (red area on the skin that is covered with small confluent bumps)
  8. Abdominal pain
  9. Colitis (inflammation of colon)
  10. Dehydration (dryness resulting from the removal of water)

60+:

  1. Diarrhoea
  2. Dyspnoea (difficult or laboured respiration)
  3. Blood alkaline phosphatase increased
  4. Bronchial obstruction (blockage of the breathing passages to the lungs)
  5. Cytomegalovirus viraemia (cytomegalo virus in blood stream)
  6. Decreased appetite
  7. Dyspnoea exertional (breathlessness or shortness of breath)
  8. Headache (pain in head)
  9. Lung infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung)
  10. Palpitations (feelings or sensations that your heart is pounding or racing)

What are the existing conditions these people have? *

  1. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 3 people, 7.89%
  2. Osteoporosis (bones weak and more likely to break): 3 people, 7.89%
  3. Fabry's Disease (build up of a particular type of fat, called globotriaosylceramide, in the body's cells): 3 people, 7.89%
  4. Acute Graft Versus Host Disease (acute complication following an allogeneic tissue/blood transplant): 3 people, 7.89%
  5. Systemic Sclerosis Pulmonary (an autoimmune or connective tissue disease. it is characterized by thickening of the skin with involvement of lungs): 2 people, 5.26%
  6. Interstitial Lung Disease: 2 people, 5.26%
  7. Idiopathic Pulmonary Fibrosis (chronic lung disease): 2 people, 5.26%
  8. Anaemia (lack of blood): 2 people, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Cellcept and Serevent?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Cellcept and Serevent:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Cellcept:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Serevent:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cellcept and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Serevent and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on mycophenolate mofetil and salmeterol xinafoate (the active ingredients of Cellcept and Serevent, respectively), and Cellcept and Serevent (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: